US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

  1. October 14, 2021

    Purdue Ch. 11 Plan Challenges Won't Hit 2nd Circ. Right Away

    A New York bankruptcy judge on Thursday denied a motion from parties appealing the confirmation of Purdue Pharma's Chapter 11 plan to bypass the normal appellate channels and bring their arguments directly to the Second Circuit.

  2. October 12, 2021

    Purdue Ch. 11 Appeals To Be Heard Before Plan Effective Date

    A Manhattan federal judge said Tuesday that she would hear oral arguments in the appeals of Purdue Pharma's Chapter 11 plan on Nov. 30 after adopting a briefing schedule proposed by the debtors and saying that she is committed to an expedited appeal process.

  3. October 08, 2021

    Canadian Creditors Seek Direct Appeal Of Purdue Ch. 11 Plan

    A group of Canadian creditors told a New York bankruptcy judge that they support consolidating the appeals for Purdue Pharma's Chapter 11 plan and that those appeals should be allowed to move directly to the Second Circuit.

  4. September 24, 2021

    California AG Announces Appeal Of Purdue Ch. 11 Plan

    California Attorney General Rob Bonta on Friday became the latest attorney general to announce an appeal of the approval of Purdue Pharma's Chapter 11 plan, saying the OxyContin maker's former owners in the Sackler family must be held accountable for their part in the opioid crisis.

  5. September 22, 2021

    US Trustee Challenges Constitutionality Of Purdue Releases

    The nondebtor, third-party releases included in Purdue Pharma's Chapter 11 plan are unconstitutional, the U.S. Trustee's Office has argued, asking a New York bankruptcy judge to wait until a higher court rules on the federal watchdog's challenge to the releases.

  6. September 16, 2021

    US Trustee To Appeal Sackler Releases In Purdue Ch. 11

    The U.S. Trustee's Office has told a New York bankruptcy judge it will appeal his order approving Purdue Pharma's Chapter 11 plan, saying the plan's liability releases for Purdue's Sackler family now-former owners go beyond the law and undermine confidence in the system.

  7. September 13, 2021

    Purdue Pharma Gets OK For $7.1M In Exec Incentives

    A New York bankruptcy judge gave Purdue Pharma permission Monday to make incentive payments of up to $7.1 million to its top executives, rejecting arguments that the executives had not done enough to clean up the company's corporate culture.

  8. September 01, 2021

    Purdue Pharma Ch. 11 Plan Gets OK With Sackler Releases

    A New York bankruptcy judge on Wednesday approved OxyContin maker Purdue Pharma's Chapter 11 plan, including contentious opioid liability releases for the company's now-former Sackler family owners.

  9. August 27, 2021

    Sacklers Agree To Forgo Non-Opioid Ch. 11 Releases

    Purdue Pharma told a New York bankruptcy judge on Friday that its owners in the Sackler family will no longer be getting releases for non-opioid liability, but liability immunity related to opioid claims will remain, as the hearing on the final decision on its Chapter 11 plan has been postponed.

  10. August 25, 2021

    Purdue Ch. 11 Judge Says Sackler Releases Should Be Tighter

    A New York bankruptcy judge on Wednesday urged Purdue Pharma to narrow the nonopioid liability releases it is granting members of its owning Sackler family as he prepared to make his judgment on Purdue's Chapter 11 plan on Friday.